Serving leading biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving leading biopharmaceutical companies globally:
Generated: October 23, 2017
| Tradename: | 1 |
| Applicant: | 1 |
| Ingredient: | 1 |
| Patents: | 3 |
| Formulation / Manufacturing: | see details |
| Mechanism of Action | Factor Xa Inhibitors |
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
ELIQUIS |
apixaban |
TABLET;ORAL | 202155 | NDA | E.R. Squibb & Sons, L.L.C. | 0003-0893 | 0003-0893-21 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0893-21) |
ELIQUIS |
apixaban |
TABLET;ORAL | 202155 | NDA | E.R. Squibb & Sons, L.L.C. | 0003-0893 | 0003-0893-31 | 10 BLISTER PACK in 1 CARTON (0003-0893-31) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
| Approval Date: | Dec 28, 2012 | TE: | RLD: | Yes | |||||
| Regulatory Exclusivity Expiration: | Aug 21, 2017 | ||||||||
| Regulatory Exclusivity Use: | INDICATED FOR THE TREATMENT OF DEEP VEIN THROMBOSIS (DVT) | ||||||||
| Regulatory Exclusivity Expiration: | Aug 21, 2017 | ||||||||
| Regulatory Exclusivity Use: | INDICATED TO REDUCE THE RISK OF RECURRENT DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM (PE) FOLLOWING INITIAL THERAPY | ||||||||
| Regulatory Exclusivity Expiration: | Dec 28, 2017 | ||||||||
| Regulatory Exclusivity Use: | NEW CHEMICAL ENTITY | ||||||||
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 23,001 others who get our Drug Patent Expiration Alerts:
